FDA approves triple-therapy inhaler for COPD

The Food and Drug Administration has approved Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol), a triple-therapy inhaler ...

[sam_pro id=0_12 codes="true"]
[sam_pro id=0_6 codes="false"]